A team of University of California, San Diego researchers has designed new compounds that mimic those naturally used by the body to regulate blood pressure. The most promising of them may literally be the key to controlling hypertension, switching off the signaling pathways that lead to the deadly condition. … Read the full story from the UCSD Newsroom
Senior author of the study report is Daniel T. O’Connor, MD, professor of pharmacology and professor of medicine in the Division of Nephrology-Hypertension. O’Connor directs the UC San Diego Hypertension Research Program and Hypertension Research Group.
Other Department of Medicine coauthors are Sushil K. Mahata, PhD, professor of medicine and pharmacology; and project scientist Nilima Biswas, PhD. Mahata is also a Veterans Affairs San Diego Healthcare System investigator.
Citation for the study report: Igor F. Tsigelny, Valentina L. Kouznetsova, Nilima Biswas, Sushil K. Mahata, Daniel T. O’Connor, Development of a pharmacophore model for the catecholamine release-inhibitory peptide catestatin: Virtual screening and functional testing identify novel small molecule therapeutics of hypertension, Bioorganic & Medicinal Chemistry, Available online 17 July 2013, ISSN 0968-0896, http://dx.doi.org/10.1016/j.bmc.2013.07.008. | Full text (UCSD only)